Amphastar Pharmaceuticals Inc Earnings

Amphastar Pharmaceuticals Inc’s revenue fell -1.83% since last year same period to $183.11Mn in the Q4 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -4.55% fall in its revenue since last 3-months.

Amphastar Pharmaceuticals Inc’s net profit fell -35.65% since last year same period to $24.43Mn in the Q4 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 40.8% jump in its net profits since last 3-months.

Amphastar Pharmaceuticals Inc’s net profit margin fell -34.45% since last year same period to 13.34% in the Q4 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 47.52% jump in its net profit margins since last 3-months.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.79 - a -14.12% fall from last quarter’s estimates.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.79.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Amphastar Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.